In a step to empower individuals to better understand their health and make informed decisions at the right time, M42, a global health leader powered by AI, technology and genomics, and its world-leading renal care business, Diaverum, has launched kidney.com, a new AI-powered kidney health assistant.
The platform has been launched in the UAE, France, Germany, Portugal, and the UK, with additional markets to follow. Kidney.com aims to raise awareness to help enhance the health outcomes of those with kidney conditions. Studies show that well-informed patients are less likely to be hospitalised and even less likely to visit emergency departments, underscoring how education improves outcomes, and supports health systems.
Designed to make trusted, personalised kidney health education more accessible at no cost, the platform’s conversational AI interface is trained on trusted clinical sources, evidence-based content and tailored learning experiences that adapt to each user’s needs. Kidney.com was developed in collaboration with more than 30 nephrologists, physicians, and nurses spanning 13 countries, and by completing over 14,000 chat interactions during the testing phase to ready the platform for real-world use.
Additional features include voice control, product label interpretation via file upload, and multilingual support, with English, Arabic, French, German, and Portuguese interfaces live, and additional languages coming soon.
Dimitris Moulavasilis, Group Chief Executive Officer, M42, said: “At M42, we are reimagining how technology can empower healthier lives. Kidney.com harnesses the power of advanced, natural-language AI to help address one of the world’s fastest-growing lifestyle-related conditions. By combining trusted clinical expertise with intelligent technology, kidney.com helps make informed health decisions. This is a prime example of how responsible AI can make care smarter, empowering people to manage, prevent, and ultimately reverse, the trajectory of chronic kidney disease.”
Chronic kidney disease (CKD) is also among the costliest chronic diseases for healthcare systems. In the United Arab Emirates, CKD prevalence is estimated to be between 4 per cent and 5 per cent of adults, increasing with age. These risk factors reinforce the importance of early education, prevention, and self-management.
Rafael Romanini, Chief Executive Officer, Diaverum, said: “At Diaverum, combining science with compassion for meaningful progress in renal care is at the core of our DNA. With kidney.com, we’re extending that philosophy into the digital world, using AI-powered education to make kidney health knowledge accessible, relevant, and actionable for everyone, anywhere, 24/7. This initiative reflects our broader commitment to helping people live fulfilling lives by slowing or even preventing disease progression through education, prevention, and innovation.”
Kidney.com reflects a broader shift toward proactive and preventive-focused systems designed to support real-world care. While not a medical device and not designed to diagnose or recommend treatment, kidney.com complements professional medical guidance, supports proactive self-management, and has been developed in line with applicable privacy and data protection regulations across markets.
Dr Fernando Macario, Chief Medical Officer, M42, said: “Education has always been at the heart of good medicine. When people understand their condition, they’re more engaged and empowered in their care. We have seen time and time again that this improves adherence, reduces complications, and contributes directly to better outcomes. Kidney.com translates complex, specific renal care knowledge into simple, evidence-based guidance that enhances, not replaces, the vital role of clinicians. It supports healthcare teams by fostering informed conversations and shared decision-making, helping doctors deliver more personalised, preventive, and effective care.”
The launch of kidney.com by M42 underscores the company’s commitment to build next-generation healthcare systems powered by AI, data, and intelligence. It sets a new standard beyond general AI, with clinically specialised, human-centred systems transforming trusted knowledge into everyday understanding to empower individuals and support smarter, data-driven care.
